India | Imports and Exports | World | Medicaments (excluding goods of heading 3002, 3005 or 3006) for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale | Value (US$) and Value Growth, YoY (%) | 2011 - 2022
| Commodity | Reporter | Partner | Trade flow | Indicator | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
| 3004. Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale | India | World | Exports | Value (US$) | 7,003,412,111.00 | 8,404,489,276.00 | 10,313,988,880.00 | 10,302,729,550.00 | 11,235,590,420.00 | 11,612,016,984.00 | 11,530,334,809.50 | 12,789,708,281.52 | 14,638,750,839.05 | 16,635,015,291.02 | 17,122,452,799.31 | 17,450,224,865.30 |
| Value Growth, YoY (%) | 35.95 | 20.00 | 22.71 | -0.10 | 9.05 | 3.35 | -0.70 | 10.92 | 14.45 | 13.63 | 2.93 | 1.91 | ||||
| Imports | Value (US$) | 893,734,410.00 | 1,113,023,075.00 | 978,708,180.00 | 859,327,097.00 | 845,371,224.00 | 927,751,598.00 | 1,029,139,502.84 | 1,062,750,650.20 | 1,287,722,247.89 | 1,059,499,900.26 | 1,771,046,017.17 | 1,127,537,136.62 | |||
| Value Growth, YoY (%) | 13.78 | 24.53 | -12.06 | -12.19 | -1.62 | 9.74 | 10.92 | 3.26 | 21.16 | -17.72 | 67.15 | -36.33 |
The value of exports of commodity group 3004 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale" from India totalled $ 17.4 billion in 2022. Sales of commodity group 3004 from India went up by 1.91% compared to 2021: exports of commodity group 3004 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale" went up by $ 327 million (cumulative exports of commodity group 3004 from India amounted $17.1 billion in 2021)
Exports of commodity group 3004 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale" amounted to 3.85% of total exports from India (cumulative merchandise exports from India totalled $ 452 billion in 2022). The share of commodity group 3004 in total exports from India decreased by 0.482 p.p. compared to 2021 (it was 4.33% in 2021 and cumulative exports from India were equal to $ 394 billion).
Exports of commodity group 3004 amounted to 88% of total sales of group "" from India in 2022 (the value of exports of commodity group from India amounted to $19.7 billion in 2022). The share of exports of commodity group 3004 in sales of commodity group from India increased by 0.357 p.p. compared to 2021 (it was 87% in 2021, and exports of commodity group from India were $19.4 billion).
Where does India export Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale?
Top export destinations of "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale" from India in 2022:
- USA with a share of 36% (6.41 billion US$)
- South Africa with a share of 3.19% (558 million US$)
- Belgium with a share of 3.12% (544 million US$)
- United Kingdom with a share of 2.93% (511 million US$)
- France with a share of 2.39% (417 million US$)
- Nigeria with a share of 2.35% (410 million US$)
- Russia with a share of 2.3% (402 million US$)
- Canada with a share of 2.09% (365 million US$)
- Australia with a share of 1.93% (337 million US$)
- Brazil with a share of 1.84% (322 million US$)
Exports structure of 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale - from India in 2022 represented by the following main commodity groups:
- 85% (14.8 billion US$): 300490 - Medicaments; consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
- 6.44% (1.12 billion US$): 300420 - Medicaments cont. other antibiotics (excl. of 3004.10), put up in measured doses/forms/packings for retail sale
- 3.29% (575 million US$): 300410 - Medicaments cont. penicillins/derivatives thereof with a penicillanic acid structure/streptomycins/their derivatives, put up in measured doses/forms/packings for retail sale
- 1.51% (264 million US$): 300450 - Medicaments cont. vitamins/other products of 29.36 (excl. of 3004.10-3004.40), put up in measured doses/forms/packings for retail sale
- 0.833% (145 million US$): 300439 - Medicaments cont. hormones/other products of 29.37 but not cont. antibiotics, put up in measured doses/forms/packings for retail sale
- 0.822% (143 million US$): 300432 - Medicaments cont. corticosteroid hormones, their derivatives & structural analogues, put up in measured doses/forms/packings for retail sale
- 0.554% (96 million US$): 300431 - Medicaments cont. insulin, put up in measured doses/forms/packings for retail sale
The value of imports of commodity group 3004 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale" to India totalled $ 1.12 billion in 2022. Sales of commodity group 3004 to India decreased by 36% in value terms compared to 2021. imports of commodity group 3004 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale" decreased by $ 643 million (the value of imports of commodity group 3004 to India was equal to $1.77 billion in 2021)
Imports of commodity group 3004 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale" accounted for 0.153% of total import flow to India (in 2022, total imports to India amounted to $ 732 billion). The share of commodity group 3004 in total imports to India decreased by 0.156 p.p. compared to 2021 (it was 0.31% in 2021 and cumulative imports to India were equal to $ 570 billion).
Imports of commodity group 3004 reached 41% of total imports of group "" to India in 2022 (imports of commodity group to India totalled $2.73 billion in 2022). The share of purchases of commodity group 3004 in imports of commodity group to India went down by 12.4 p.p. compared to 2021 (it was 53% in 2021, and imports of commodity group to India accounted for $3.29 billion).
Where does India import Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale from?
Top trading partners (import of "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale") of India in 2022:
- Switzerland with a share of 15.2% (172 million US$)
- USA with a share of 14.6% (165 million US$)
- Denmark with a share of 12.2% (138 million US$)
- Germany with a share of 10.7% (121 million US$)
- Belgium with a share of 9.83% (110 million US$)
- Brazil with a share of 6.24% (70 million US$)
- Netherlands with a share of 4.39% (49 million US$)
- United Kingdom with a share of 4.26% (48 million US$)
- Italy with a share of 4.09% (46 million US$)
- France with a share of 3.49% (39 million US$)
Imports structure of 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale - to India in 2022 represented by the following main commodity groups:
- 70% (797 million US$): 300490 - Medicaments; consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
- 18.3% (207 million US$): 300431 - Medicaments cont. insulin, put up in measured doses/forms/packings for retail sale
- 4.42% (49 million US$): 300439 - Medicaments cont. hormones/other products of 29.37 but not cont. antibiotics, put up in measured doses/forms/packings for retail sale
- 4.1% (46 million US$): 300420 - Medicaments cont. other antibiotics (excl. of 3004.10), put up in measured doses/forms/packings for retail sale
- 0.701% (7.91 million US$): 300450 - Medicaments cont. vitamins/other products of 29.36 (excl. of 3004.10-3004.40), put up in measured doses/forms/packings for retail sale
- 0.443% (4.99 million US$): 300432 - Medicaments cont. corticosteroid hormones, their derivatives & structural analogues, put up in measured doses/forms/packings for retail sale
- 0.399% (4.5 million US$): 300410 - Medicaments cont. penicillins/derivatives thereof with a penicillanic acid structure/streptomycins/their derivatives, put up in measured doses/forms/packings for retail sale
